In briefBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e4824 (Published 17 July 2012) Cite this as: BMJ 2012;345:e4824
Drugs agency consults on early access to drugs in development: The UK Medicines and Healthcare Products Regulatory Agency has launched a 12 week public consultation on proposals to launch a scheme that gives patients with life threatening, chronic, or debilitating conditions early access to drugs that are still being developed, usually having completed phase III trials but sometimes having just completed phase II. Comments can be emailed to the agency at firstname.lastname@example.org until 5 October.
Doctors need to learn about prescribing exercise: Too few …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial